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In traumatic brain injury (TBI), preliminary retrospective work on signal entropy suggests an 
association with global outcome. The goal of this study was to provide multi-center validation of 
the association between multi-scale entropy (MSE) of cardiovascular and cerebral physiologic 
signals, with 6-month outcome. Using the Collaborative European NeuroTrauma Effectiveness 
Research in TBI (CENTER-TBI) high-resolution intensive care unit (ICU) cohort, we selected 
patients with a minimum of 72 hours of physiologic recordings, and a documented 6-month 
Glasgow Outcome Scale Extended (GOSE) score. 10- second summary data for heart rate 
(HR), mean arterial pressure (MAP), intracranial pressure (ICP) and pulse amplitude of ICP 
(AMP), were derived across the first 72 hours of data. MSE complexity index (MSE-Ci) was 
determined for HR, MAP, ICP and AMP, with the association between MSE and dichotomized 
6-month outcomes assessed using Mann-Whitney-U testing and logistic regression analysis. A 
total of 160 patients had a minimum of 72 hours of recording and a documented outcome. 
Decreased HR MSE-Ci (7.3 (IQR 5.4 to 10.2) vs. 5.1 (IQR 3.1 to 7.0); p=0.002), lower ICP MSE-
Ci (11.2 (IQR 
 
7.5 to 14.2) vs. 7.3 (IQR 6.1 to 11.0); p=0.009) and lower AMP MSE-Ci (10.9 (IQR 8.0 to 13.7) 
vs. 8.7 (IQR 
 
6.6 to 11.0); p=0.022), were associated with death. Similarly, lower HR MSE-Ci (8.0 (IQR 6.2 to 
10.9) vs. 
 
6.2 (IQR 3.9 to 8.7); p=0.003) and lower ICP MSE-Ci (11.4 (IQR 8.6 to 14.4) vs. 9.2 (IQR 6.0 to 
13.5)), were 
 
associated with unfavourable outcome. Logistic regression analysis confirmed that lower HR 
MSE-Ci and ICP MSE-Ci were associated with death and unfavourable outcome at 6-months. 
These findings suggest that a reduction in cardiovascular and cerebrovascular system entropy 
is associated with worse outcomes. Further work in the field of signal complexity in TBI multi-









































Signal complexity, which is quantifiable using various entropy surrogate measures, has been 
explored as a means to estimate a systems ability to accommodate future change.1 Within 
biological systems, physiologic signal complexity relates to integrative homeostatic status and 
has been shown to be associated with global outcomes, across a range of pathologies.1–7 In 
particular, reduced complexity or entropy in heart rate (HR) or arterial blood pressure (ABP), 
has been shown to be associated with worse outcomes in cardiac and critical care literature.6,8–
11 It is believed that reduced complexity reflects a more rigid biological system, less capable of 
accommodating perturbations or new insults. 
In the traumatic brain injury literature, some preliminary work has been conducted exploring 
both heart rate variability (HRV) and approximate entropy, in association with 6-month 
outcomes.3,12–15 These preliminary studies, though based on retrospective data sets, have 
demonstrated strong associations between reduced signal complexity, and poor outcome in 
TBI. In particular, a reduction in HRV, approximate entropy of HR, intracranial pressure (ICP), 
and mean arterial pressure (MAP), have all displayed some association with 6-month outcome 
in TBI.14 These findings, support that potentially a multi-system approach to entropy be 
considered, where a decreased ability to compensate in both the cerebral (ICP) and 
cardiovascular (HR and MAP) biological systems, may contribute to poor outcome in 
moderate/severe TBI. 
The main limitation of these previous works is that they are primarily retrospective, single center 
studies. Similarly, adopting new multi-scale entropy (MSE) techniques, has yet to be fully 
explored in a multi-center adult TBI data set in association with outcome. MSE provides a 
comprehensive assessment of signal entropy over various time scales for a given physiologic 
variable. Furthermore, the relationship between MSE and other multi-modal monitoring aspects 
of cerebral physiology associated with 6-month outcome, such as continuously assessed 
cerebrovascular reactivity or cerebral compensatory reserve, has only been preliminarily 
explored.3,16–18 Using the prospective multi-center high-resolution data set from the Collaborative 
European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI), we 
aim to explore MSE of raw physiologic signals, their relationship to 6-month outcome and 







All patients from the multi-site CENTER-TBI high resolution intensive care unit (ICU) monitoring 
cohort with a minimum of 72 hours of high-frequency physiologic data and with a 6-month 
Glasgow Outcome Scale – Extended (GOSE) score, were included in this analysis. Patients 
with EVD based ICP data only i.e. no parenchymal sensor were excluded given the interrupted 
nature of their recordings (i.e. reliable ICP can be recorded only when the drainage is closed). 
These patients were prospectively recruited between January 2015 and December 2017 from 
21 centers in the European Union (EU). All patients were admitted to ICU for their TBI during the 
course of the study, with high frequency digital signals recorded from their ICU monitors during 
the course of their ICU stay. As part of the inclusion criteria into the high- resolution cohort of 
CENTER-TBI, all patients had invasive ICP monitoring in place, with data recording within 24 
hours of their injury to ensure early capture of data. All patients suffered predominantly from 
moderate to severe TBI (moderate = Glasgow Coma Score (GCS) 9 to 12, and severe = GCS of 
8 or less). 
A minority of patients were categorised at the time of admission as suffering from less severe 
TBI, but experienced subsequent early deterioration leading to ICU admission for care and 
monitoring. All patients in this cohort had invasive ICP monitoring conducted in accordance 
with the Brain Trauma Foundation guidelines.19 Including targeting an ICP threshold of 20 







Data used in these analyses were collected as part of the CENTER-TBI study which had 
individual national or local regulatory approval; the UK Ethics approval is provided as an 
exemplar: (IRAS No: 150943; REC 14/SC/1370). The CENTER-TBI study (EC grant 602150) 
has been conducted in accordance with all relevant laws of the EU if directly applicable or of 
direct effect and all relevant laws of the country where the Recruiting sites were located, 
including but not limited to, the relevant privacy and 
data protection laws and regulations (the “Privacy Law”), the relevant laws and regulations on the use of 
human materials, and all relevant guidance relating to clinical studies from time to time in force 
including, but not limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice 
(CPMP/ICH/135/95) (“ICH GCP”) and the World Medical Association Declaration of Helsinki entitled 
 
“Ethical Principles for Medical Research Involving Human Subjects”. Informed Consent by the patients 
and/or the legal representative/next of kin was obtained, accordingly to the local legislations, for 






As part of recruitment to the multi-center high resolution ICU cohort of CENTER-TBI, all patients 
had demographics, injury and imaging data prospectively recorded. Similarly, all patients had 
high frequency digital signals from ICU monitoring recorded throughout their ICU stay, with the 
goal of initiating recording within 24 hours of ICU admission. All digital ICU signals were further 
processed (see Signal Acquisition/Signal Processing). For the purpose of this study, basic 
admission demographics and centrally reported computed tomography (CT) variables for the 
first available CT of each patient were extracted.20 They included: age, admission best GCS 
motor score and pupillary reactivity (bilaterally reactive, unilateral reactive, bilateral unreactive), 
Marshall CT Classification,21 Rotterdam CT score,22 Helsinki CT score,23 presence or absence 
of traumatic subarachnoid haemorrhage (tSAH), extradural hematoma (EDH), pre-hospital 
hypotension (defined as a recorded systolic blood pressure <90 mmHg) and pre-hospital 
hypoxia (defined as a recorded oxygen saturation of <= 92%). Glasgow Outcome Scale 
Extended (GOSE) scores at 6-months were also obtained from the database where available. 




Arterial blood pressure (ABP) was obtained through arterial lines connected to pressure 
transducers. ICP was acquired from an intra-parenchymal strain gauge probe (Codman ICP 
MicroSensor; Codman & Shurtleff Inc., Raynham, MA), parenchymal fibre optic pressure 
sensor (Camino ICP Monitor, Integra Life Sciences, Plainsboro, NJ, United States; 
https://www.integralife.com/). All signals were recorded using digital data transfer or digitized 
via an A/D converter (DT9803; Data Translation, Marlboro, MA), where appropriate; sampled at 
frequency of 100 Hertz (Hz) or higher, using the ICM+ software (Cambridge Enterprise Ltd, 
Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk) or Moberg CNS Monitor (Moberg 
Research Inc, Ambler, PA, USA, https://www.moberg.com) or a combination of both. Signal 
artefacts 
 
were removed using both manual and automated methods prior to further processing or 







Post-acquisition processing of the above signals was conducted using ICM+ (Cambridge 
Enterprise Ltd, Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk). Similar processing has 
occurred in other CENTER- TBI studies.25–30 All signal data were filtered to only include the first 
72 hours of recording, in order to focus on the acute phase of physiology during the ICU stay. 
This 72 hour time period of data was chosen for two reasons. First, it represents the period 
post-TBI where we would expect the greatest degree of physiology change/response to injury 
during active treatment. Second, many patients in the high- resolution cohort for CENTER-TBI 
only had ~3 days of physiologic data capture. 
CPP was determined as MAP – ICP. Pulse amplitude of ICP (AMP) was determined by 
calculating the fundamental Fourier amplitude of the ICP pulse waveform over a 10 second 
window, updated every 10 seconds. Ten second moving averages (updated every 10 seconds 
to avoid data overlap) were calculated 
for all recorded signals: heart rate (HR), ICP, ABP (which produced MAP), AMP, and CPP. This 
10-second by 10-second data was utilized for the determination of MSE (see MSE determination 





In addition, we desired to compare MSE of various raw physiologic measures with 
cerebrovascular reactivity and compensatory reserve, using the first 72 hours of data. As such, 
we derived PRx as the moving correlation coefficient between 30 consecutive 10 second mean 
windows of ICP and MAP, updated every minute. Similarly, RAP (correlation (R) between AMP 
(A) and ICP (P)) was determined as the moving correlation coefficient between 30 consecutive 
10 secondary mean windows of AMP and ICP, updated every minute. Minute-by-minute data 
was then derived for these indices and the raw physiology (ICP, MAP, AMP, and CPP). Grand 
mean values of all physiologic variables were calculated per patient, across the first 72 hours of 
data. In addition, the following post-processing of this physiologic data occurred in R (R Core 
Team (2018). R: A language and environment for statistical computing. R Foundation for 
Statistical Computing, Vienna, Austria. URL https://www.R-project.org/): 
a. % Time Spent with ICP Above 20 mmHg and 22 mmHg.19 
 
b. % Time with CPP below 60 mmHg, and above 70 mmHg.19 
 
c. % Time Spent with PRx Above Threshold: For each patient the % of time spent 
above the following clinically defined thresholds were calculated: 0, +0.25, 
+0.35.31,32 All of these thresholds for PRx have been defined in previous 
published literature as statistically significant for association with 6-month global 
outcome in adult TBI patients. 
d. Given the difficulty in interpretation of RAP, we derived the area under the curve 
(RAP- AUC) over time for the first 72 hours, integrating the signal via linear 









MSE calculations were conducted for each patient over the 72-hour period of monitoring, 
deriving the summary complexity index (MSE-Ci) for each raw physiologic parameter: HR, MAP, 
ICP and AMP. A full description of MSE background and theory is beyond the scope of this 
manuscript, and has been covered in detail in other works in neurocritical care.3,4,18,36 The 
referenced literature should serve as a source for those interested in the details of sample 
entropy (SampEn) and MSE.1,3,36 However, in short, MSE serves as a method to estimate the 
complexity/non-linear dynamic properties of a signal or time- series variable, based on more 
than one scale of time. It accomplishes this through the determination of SampEn for over 
various time scales for a given signal, with different time scales derived through application of 
non-overlapping averaging of data. In particular, a scale of 1 represents the native signal (ie. in 
our case 10-second by 10-second data), where a scale of τ (τ > 1) represents a coarse-grained 
time series obtained by averaging of every τ consecutive samples from the native signal. For our 
SampEn calculations, we used a tolerance (r) of 0.15 and an embedding dimension (m) of 2, in 
keeping with previous literature on the topic.3,4,36 For the purpose of our analysis we determined 
MSE over 20 scales, which has previously been conducted using physiologic signals in 




Once SampEn has been determined for each scale, across the 72-hour period of physiology, 
then the MSE-Ci was determined as a summary measure output for MSE. This was 
accomplished through deriving the area under the MSE curve (ie. SampEn vs. Scale curve) 
for each patient through numerical 
integration of SampEn in the range of scales from 1 to 20. This subsequently led to the 









All statistical analysis was conducted using R. Normality of continuous variables was 
assessed via Shapiro-Wilks test, where all variables displayed non-parametric characteristics, 
and are hence presented as median (range) or median (IQR). Error bars for SampEn over the 
various scales were produced for the entire population dichotomized by outcome. The alpha 
for all statistical tests performed was set at 0.05, with no specific correction for multiple 
comparisons, given the exploratory nature of this work. 
MSE-Ci values and physiologic measures were compared using Pearson correlation 
coefficients. MSE-Ci, other physiologic measures and demographic data were compared 
between dichotomized 6-month outcome groups, using Mann-Whitney-U and chi-square 
testing, where appropriate. GOSE was dichotomized into: Alive/Dead, and 
Favourable/Unfavourable (with less than or equal to 4 denoting unfavourable outcome). To 
assess the association between MSE-Ci values and outcome, univariate logistic regression 
(ULR) was conducted for both dichotomized GOSE defined outcomes. ULR was also 
performed for admission patient demographics and the cerebral physiologic metrics highlighted 
above in th “Signal Processing” portion of the methods. Area under the receiver operating curve 
(AUC), 95% 
confidence intervals (CI’s) and p-values for the univariate models are reported. All AUC’s and 95% CI’s 
for ULR were determined using bootstrapping techniques with 2000 iterations, with only the 
statistically significant results reported. Further assessment between MSE-Ci values and 
dichotomized outcomes was conducted using multi-variable logistic regression (MLR) models, 
adjusting for baseline admission 
characteristics. Finally, MLR models assessing MSE-Ci and outcomes were created adjusting 











A total of 160 patients met the inclusion criteria of having at least 72 hours of high-resolution 
physiology and a recorded 6 month GOSE. The median age was 49 years (IQR: 29 to 62), with 
128 (80.0%) being male. The median admission GCS total and motor sub-scores were 6 (IQR: 
3 to 9) and 4 (IQR: 1 to 5), respectively. The median admission Marshall CT grade was 4 (IQR: 
2 to 6), with 27 (16.9%) and 23 (14.4%) patients have a history of pre-hospital hypoxia and 
hypotension, respectively. Twenty-eight (17.5%) and 15 (9.4%) patients presented with 
bilaterally fixed and unilaterally fixed pupils, respectively. Appendix A outlines the patient 
demographics and physiologic characteristics between dichotomized outcome groups: 




Entropy Differences Between Outcome Groups – Mann-Whitney-U/Chi-Square Testing 
 
SampEn was determined for scales 1 through 20 for each patient. In order to determine if there 
was a difference between SampEn for dichotomized outcome groups, we generated population 
based descriptive error bar plots for: HR, MAP, ICP and AMP. Figure 1 provides the error bar 
plots for SampEn vs. Scale for Alive versus Dead patient cohorts, whereas Figure 2 provides 
these error bar plots for Favourable vs. Unfavourable patient cohorts. In general, across the 
population, those falling into dead or unfavourable categories at 6 months post-injury displayed 
lower SampEn compared to alive and 
favourable outcome patients, regardless of the scale used. This suggests that more rigid 
cardiovascular (ie. HR and MAP) and cerebral (ie. ICP and AMP) systems are associated with 

















To explore this relationship between signal complexity and dichotomized outcomes further, we 
analyzed differences in MSE-Ci using Mann-Whitney-U. Table 1 provides the comparison of 
physiologic variables between dichotomized outcome groups, with p-values for Mann-Whitney-U 
testing reported. 
Differences between admission demographic variables can be seen in Appendix A of the 
supplementary materials. In keeping with other studies from the CENTER-TBI high-resolution 
data set, elevated mean ICP (p<0.0001), AMP (p=0.002) and PRx (p=0.002), were associated 
with death at 6 months.25,30 Similar relationships were not found for association with 
unfavourable 6-month outcomes. Evaluating MSE-Ci in association with mortality at 6-months, 
lower HR MSE-Ci (7.3 (IQR 5.4 to 10.2) vs. 5.1 (IQR 3.1 to 7.0); 
p=0.002), lower ICP MSE-Ci (11.2 (IQR 7.5 to 14.2) vs. 7.3 (IQR 6.1 to 11.0); p=0.009) and lower 
AMP 
 
MSE-Ci (10.9 (IQR 8.0 to 13.7) vs. 8.7 (IQR 6.6 to 11.0); p=0.022), were associated with death. 
Similarly, 
 
lower HR MSE-Ci (8.0 (IQR 6.2 to 10.9) vs. 6.2 (IQR 3.9 to 8.7); p=0.003) and lower ICP MSE-Ci 
(11.4 (IQR 
 






Association of MSE with Dichotomized Outcomes – Logistic Regression Analysis 
 
Employing logistic regression techniques, we then further evaluated the association between 
MSE-Ci values and 6-month dichotomized outcomes. Table 2 provides the results of 
univariate logistic regression analysis for MSE-Ci variables, in association with both 
dichotomized outcomes. 
Supplementary Appendix B provides the univariate logistic regression analysis results for the 
admission demographics and cerebral physiologic metics. In keeping with the Mann-Whitney-U 
testing, HR MSE-Ci and ICP MSE-Ci were found to be statistically associated with both 6-month 
dichotomized outcomes. 
Creating MLR models, adjusting for admission age, pupillary status and GCS motor score, only 
HR MSE-Ci variables remained statistically significant in association with 6-month dichotomized 
outcomes (AUC 0.674, 95% CI 0.550-0.786 , p=0.003; AUC 0.607, 95% CI 0.516-0.699, 
p=0.014; for alive/dead and 
favourable/unfavourable outcome respectively). Similarly, evaluating MLR models adjusting 
for admission characteristics and both mean ICP and PRx, only HR MSE-Ci remained 
statistically significant in association with favourable/unfavourable outcome at 6-months (AUC 
0.630, 95% CI 0.541-0.7171, p=0.034). 





Correlations Between MSE and Cerebral Physiology 
 
Using the first 72 hours of recorded data, we compared MSE-Ci variables to cerebral 
physiologic variables over that time period using Pearson linear correlation coefficients. HR 
MSE-Ci displayed a weak negative correlation with % time with ICP above 20 mmHg (r= -
0.284, p=0.0003) and ICP above 22 mmHg (r= -0.262, p=0.0008). MAP MSE-Ci displayed 
weak negative correlations with: % time with ICP above 20 mmHg (r= -0.167, p=0.03), ICP 
above 22 mmHg (r= -0.184, p=0.02), PRx above 0 (r= -0.226, p=0.004), PRx above +0.25 (r= -
0.170, p=0.03), and PRx above +0.35 (r= -0.166, p=0.04). ICP MSE-Ci 
displayed weak negative correlations with: % time with PRx above 0 (r= -0.178, p=0.02), PRx 
above +0.25 (r= -0.161, p=0.04), and PRx above +0.35 (r= -0.161, =0.04). Finally, AMP MSE-Ci 
displayed weak negative correlations with: % time with ICP above 20 mmHg (r= -0.168, p=0.03) 
and % time with ICP above 22 mmHg (r= -0.198, p=0.01). No statistically significant correlation 
was identified between RAP or RAP AUC measures and MSE-Ci metrics. 
Discussion: 
 
Through exploration of the CENTER-TBI high-resolution ICU cohort, we have provided some 
confirmatory multi-center findings regarding signal complexity and outcome. Such findings are 
some of the worlds first in a multi-center prospectively collected high-resolution data set in TBI. 
With our cohort considered one of the largest currently available. First, in keeping with some of 
the retrospective literature on the topic, a decrease in entropy seen in HR and ICP, was 
associated with both mortality and unfavourable 6-month outcomes.3,14,16 This was confirmed 
through Mann-Whitney-U testing and logistic regression analysis. These differences in entropy 
between alive/dead and favourable/unfavourable outcome groups was also seen in the 
descriptive error bar plots of SampEn vs. Scale. The association 
with decreased entropy and outcome was preserved for HR MSE-Ci, when adjusting for 
baseline admission characteristics. These findings provide multi-center confirmation that 
decreased entropy, signifying increased system rigidity, in both the cardiovascular system (ie. 
HR) and cerebrovascular system (ie. ICP – a surrogate of pulsatile cerebral blood volume), is 
linked with poor outcome. This likely reflects both the cardiovascular and cerebrovascular 
systems inability to compensate for further perturbation or insult. We must acknowledge, this 
concept of different organ/homeostatic systems 
becoming more “rigid”, lacking compensatory capacity, and this being linked with global outcome is 
theoretical at this point. The existing literature on systemic physiology and signal complexity 
points to worse outcomes with lower entropy values in individual measures.1,4,7–11,36 This 
suggests that as signal complexity decreases, signifying a more rigid system mathematically, that 
this is associated with worse outcome. The cardiovascular literature is robust in this area, where 
metrics such as HR or pulse pressure variance/complexity are strong predictors of outcome in 
many pathologies.8,10,11 Similarly, some preliminary results in TBI literature suggest the same 
regarding HR and ICP data.4,7,14,18 Our findings 
suggest that both HR and ICP signal complexity may be important in prognostication in 
moderate/severe TBI. The exact relationship between the two is still unclear and remains 
speculative. They could represent separate distinct systems, whose signal complexity are 
independently related to global outcome in TBI. Yet, more likely is that they are closely inter-
linked, with intra-cranial changes impacting cardiovascular changes, as a function on ongoing 
secondary insult after-TBI.14 Autonomic dysfunction in TBI as a result of primary and secondary 
injuries, may be an example of such a driving mechanism linking intra-cranial and 
cardiovascular signal complexities.2,12,13 Much further work in this area is required, and we 
merely pose the theory of a multi-system aspect to signal complexity and outcome association. 
Second, decreased AMP MSE-Ci was also found to be associated with death on Mann-Whitney-
U testing. These findings, however, were not supported through logistic regression analysis. 
This association suggests the decreased complexity in a signal known to be associated with 
cerebral compensatory 
reserve, is associated with mortality. AMP is known to reflect aspects of cerebral compensatory 
reserve, and is utilized in the derivation of indices which measure aspects of compensatory 
reserve, such as RAP.17,33,34,37 Thus, decreased entropy of AMP, which may reflect increased 
rigidity in the compensatory reserve system, appears to be associated with mortality. This 
preliminary finding is in parallel to the association seen between worse RAP and compensatory 
reserve weighted ICP values, and outcome in TBI.33,34 Though it must be emphasized, these 
results for AMP MSE-Ci do require substantial validation, and reducing such complex systems 
into single entropy measures may be too simplistic. 
Third, comparing the strength of association between MSE-Ci variables and the dichotomized 
outcomes via logistic regression analysis, the overall AUC and 95% CI’s for the MSE-Ci variables were 
quite similar to the individual standard IMPACT and CT variables (see Appendix B). 
Furthermore, compared to the 
raw physiologic metrics, the AUC and 95 CI’s were also of similar magnitude to known outcome 
associates in TBI, such as ICP and PRx. Though it must be acknowledged, that they were not 
statistically different on comparison. Thus, the role for MSE-Ci variables in the development of 
more complex prognostic models in moderate/severe TBI remains unclear, as the benefit 
above and beyond standard TBI demographic and physiologic metrics has yet to be shown. 
With that said, much further work is required in the area of physiologic signal complexity and its 
role in prognostication. As such, the results here should be considered preliminary/exploratory 
and interpreted with caution. 
Fourth, in this particular cohort, MAP entropy was neither associated with outcome or found to 
be significantly different between outcome groups. This likely reflects the tight MAP control, and 
active treatment of MAP/CPP throughout the course of the patient’s ICU care. These findings 
are in contradiction to recent descriptions of the association between variability ABP data and 
both patient outcome, where such prior work suggests a link between decreased 
variance/complexity in ABP and both worse global outcome.14,16 Further work on the association 
between MAP signal complexity and both outcome and physiologic correlates in TBI is required. 
Finally, various understandable physiologic correlations were seen with MSE-Ci variables. A 
correlation between increased % time spent with ICP above 20 and 22 mmHg, and decreased 
HR MSE-Ci, MAP MSE- Ci and AMP MSE-Ci. This suggests that as ICP becomes 
progressively higher, signal complexity in both the cardiovascular (ie. HR and MAP) and 
cerebral compensatory reserve systems (ie. AMP) appear to decrease, reflecting increased 
rigidity. Similarly, increased PRx values were correlated with decreased HR MSE-Ci, MAP 
MSE-Ci and ICP MSE-Ci. This suggests that as cerebrovascular reactivity worsens, both the 
cardiovascular (ie. HR and MAP) and cerebrovascular (ie. ICP – surrogate measure of pulsatile 
cerebral blood volume) systems become less complex, and more rigid. Such findings are in 
keeping with previous approximate entropy, MSE and ICP/blood-pressure variability work done 
in moderate/severe TBI.3,14,16–18 
Clinically, MSE calculations for various aspects of the cardiovascular and cerebrovascular 
systems may prove valuable in prognostic modelling. Quantifying objectively individual body 
systems ability to accommodate perturbations, would serve invaluable both in long-term 
prognostication, but also in short term outcome an physiologic prediction. It is possible that 
information gleaned from MSE estimations may allow for more acute prediction and modelling of 
physiology “state” during the acute phase of ICU stay. Such advanced modelling may allow for the 
prediction of those more likely to fail medical management and be in need of more aggressive 
measures, such a decompressive craniectomy or application of therapeutic hypothermia. Much 






Despite the promising findings, there are some important limitations which deserve highlighting. 
First, our cohort is one of the largest prospectively collected multi-center data sets with high-
frequency digital physiology in TBI, making it uniquely positioned to investigate many question 
in TBI physiology. 
However, despite the advantages of our data set, we must acknowledge we have only 160 
patients with a minimum of 72 hours of recordings and a recorded 6-month outcome. Thus, the 
strength of conclusions that can be drawn from this work remains limited. It supports the need 
for ongoing multi- center collaborative efforts in high-resolution physiological monitoring. 
Second, patients underwent active treatment during their ICU stay which may all conceivably 
impact on homeodynamic physiologic integrity. As such, the recorded physiology does not 
necessarily reflect the natural physiologic history of TBI. Such recordings may have been 
influenced by therapeutic measures, impacting the derived entropy measures seen. The impact 
of therapeutic intensity on system entropy in TBI is a field which requires much further 
investigation. Fourth, the strength of relationships between MSE-Ci and other recorded cerebral 
physiologic variables, may not represent true weak correlations, but may suggest non-linear 
relationships between such complex physiology signals. Such non-linear analytics were not 
performed in this analysis, and do need to considered in future investigations. Future work could 
benefit from not only non-linear time-series approaches, both uni- and mulit-variate, but also 
through the application of machine learning classification techniques. This work is planned as 
part on ongoing European and Canadian collaborative effects in TBI physiology.38–40 Finally, the 
results here must be considered preliminary and exploratory in nature. The field of signal 
entropy in in TBI is in its infancy. The utility of such metrics in the bedside care of 






Decreased MSE in HR and ICP is associated with mortality and unfavourable outcome at 6-
months in moderate/severe TBI. Decreased AMP MSE may be associated with mortality. 
Increased ICP correlates with a reduction in HR, MAP and AMP MSE, whereas increased PRx 
correlates with decreased HR, MAP and ICP MSE. These findings suggest that a reduction in 
cardiovascular and cerebrovascular system 
entropy is associated with worse outcomes. The possible pathophysiological alterations 
underlying this association deserve to be explored. Further work in the field of signal 
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Figure 1: Sample Entropy vs. Scale – Population Error Bar Plots for HR, MAP, ICP and AMP – Alive/Dead Cohorts 
 
AMP = pulse amplitude of ICP, HR = heart rate, ICP = intracranial pressure, MAP = mean arterial pressure. Panel A – 
HR Sample Entropy vs. Scale Alive Cohort, Panel B – HR Sample Entropy vs. Scale Dead Cohort, Panel C – MAP 
Sample Entropy vs. Scale Alive Cohort, Panel D – MAP Sample Entropy vs. Scale Dead Cohort, Panel E – ICP 
Sample Entropy vs. Scale Alive Cohort, Panel F – ICP Sample Entropy vs. Scale Dead Cohort, Panel G – AMP 
Sample Entropy vs. Scale Alive Cohort, Panel H – AMP Sample Entropy vs. Scale Dead Cohort. 
Figure 2: Sample Entropy vs. Scale – Population Error Bar Plots for HR, MAP, ICP and AMP – 
Favourable/Unfavourable Cohorts 
 
AMP = pulse amplitude of ICP, HR = heart rate, ICP = intracranial pressure, MAP = mean arterial pressure. 
Favourable = Glasgow Outcome Scale Extended score of 5 or higher, Unfavourable = Glasgow Outcome Scale 
Extended score of 4 or less. Panel A – HR Sample Entropy vs. Scale Favourable Cohort, Panel B – HR Sample 
Entropy vs. Scale Unfavourable Cohort, Panel C – MAP Sample Entropy vs. Scale Favourable Cohort, Panel D – 
MAP Sample Entropy vs. Scale Unfavourable Cohort, Panel E – ICP Sample Entropy vs. Scale Favourable Cohort, 
Panel F – ICP Sample Entropy vs. Scale Unfavourable Cohort, Panel G – AMP Sample Entropy vs. Scale Favourable 
Cohort, Panel H – AMP Sample Entropy vs. Scale Unfavourable Cohort. 
Table 1: Summary of Patient Physiology Based on Alive/Dead or Favourable/Unfavourable Outcome Groups – 
Mann-Whitney-U Testing 
 















0.914 71.0 (62.0 to 
79.9) 









0.028 83.1 (78.0 to 
89.8) 









<0.0001 12.6 (9.6 to 
14.9) 





2.0 (1.4 to 
2.8) 
3.1 (2.0 to 
4.9) 
0.002 1.9 (1.5 to 
2.7) 







0.174 72.5 (64.8 to 
76.9) 































0.256 0.787 (0.606 
to 0.845) 









































0.0002 2.6 (1.1 to 
8.3) 







1.7 (0.4 to 
5.0) 
7.7 (1.9 to 
44.0) 
0.0001 1.9 (0.6 to 
4.0) 
























0.300 57.7 (22.1 to 
78.6) 
37.0 (20.1 to 
67.5) 
0.082 







0.002 44.5 (33.7 to 
53.2) 











0.002 22.1 (13.8 to 
28.8) 

















HR MSE-Ci 7.3 (5.4 to 
10.2) 
5.1 (3.1 to 
7.0) 
0.002 8.0 (6.2 to 
10.9) 
6.3 (3.9 to 8.7) 0.003 




0.189 13.0 (10.5 to 
15.6) 
12.0 (9.0 to 
16.2) 
0.385 
ICP MSE-Ci 11.2 (7.5 
to 14.2) 
7.3 (6.1 to 
11.0) 
0.009 11.4 (8.6 to 
14.4) 
9.2 (6.0 to 
13.5) 
0.017 
AMP MSE-Ci 10.9 (8.0 
to 13.7) 
8.7 (6.6 to 
11.0) 
0.022 10.2 (8.1 to 
13.4) 
10.1 (7.2 to 
13.0) 
0.449 
a.u. = arbitrary units, ABP = arterial blood pressure, AMP = pulse amplitude of ICP, RAP AUC = area under RAP 
over time curve, CPP = cerebral perfusion pressure, HR = heart rate, ICP = intra-cranial pressure, IQR = inter-
quartile range, MAP = mean arterial pressure, mmHg = millimeters of Mercury, MSE = multi-scale entropy, MSE-Ci 
= MSE complexity index, PRx = pressure reactivity index (correlation between ICP and MAP), RAP = correlation 
between AMP and ICP Note: all bolded p-values are those <0.05 when comparing the variables between Alive/Dead 
and Favourable/Unfavourable outcome groups. Favourable = Glasgow Outcome Scale of 5 to 8, Unfavourable = 
Glasgow Outcome Scale of 1 to 4. 
Table 2: Univariate Logistic Regression Analysis – Multi--Scale Entropy (MSE) and Dichotomized 6-Month Outcome 
 
Model AUC A/D (95% CI) AIC p-value AUC F/U (95% CI) AIC p-value 
HR MSE-Ci 0.679 (0.560-
0.783) 







159.8 0.221 0.540 (0.452-
0.630) 
221.1 0.500 
ICP MSE-Ci 0.652 (0.542-
0.749) 







158.0 0.076 0.535 (0.444-
0.623) 
221.0 0.471 
A/D = alive/dead, AMP = pulse amplitude of ICP, AIC = Akaike Information Criterion, AUC = area under the 
receiver operating curve, CI = confidence interval, F/U = Favourable/Unfavourable outcome (ie. Favourable = 
Glasgow Outcome Scale of 5 to 8; Unfavourable = Glasgow Outcome Scale of 1 to 4), HR = heart rate, ICP = intra-
cranial pressure, MAP = mean arterial pressure, MSE = multi-scale entropy, MSE-Ci = MSE complexity index. 
